KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Deferred Taxes (2021 - 2025)

Hims & Hers Health's Deferred Taxes history spans 5 years, with the latest figure at -$3.5 million for Q4 2025.

  • For Q4 2025, Deferred Taxes rose 52.43% year-over-year to -$3.5 million; the TTM value through Dec 2025 reached -$13.0 million, up 78.98%, while the annual FY2025 figure was -$13.0 million, 78.98% up from the prior year.
  • Deferred Taxes for Q4 2025 was -$3.5 million at Hims & Hers Health, down from $862000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $862000.0 in Q3 2025 and bottomed at -$54.3 million in Q3 2024.
  • The 5-year median for Deferred Taxes is -$134000.0 (2022), against an average of -$4.4 million.
  • The largest annual shift saw Deferred Taxes surged 143.75% in 2023 before it tumbled 945700.0% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$210000.0 in 2021, then dropped by 1.9% to -$214000.0 in 2022, then surged by 107.94% to $17000.0 in 2023, then crashed by 43094.12% to -$7.3 million in 2024, then surged by 52.43% to -$3.5 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Deferred Taxes are -$3.5 million (Q4 2025), $862000.0 (Q3 2025), and -$9.5 million (Q2 2025).